119 related articles for article (PubMed ID: 14998329)
21. Crystal structure of the µ-opioid receptor bound to a morphinan antagonist.
Manglik A; Kruse AC; Kobilka TS; Thian FS; Mathiesen JM; Sunahara RK; Pardo L; Weis WI; Kobilka BK; Granier S
Nature; 2012 Mar; 485(7398):321-6. PubMed ID: 22437502
[TBL] [Abstract][Full Text] [Related]
22. In vivo photopharmacology with light-activated opioid drugs.
McClain SP; Ma X; Johnson DA; Johnson CA; Layden AE; Yung JC; Lubejko ST; Livrizzi G; He XJ; Zhou J; Chang-Weinberg J; Ventriglia E; Rizzo A; Levinstein M; Gomez JL; Bonaventura J; Michaelides M; Banghart MR
Neuron; 2023 Dec; 111(24):3926-3940.e10. PubMed ID: 37848025
[TBL] [Abstract][Full Text] [Related]
23. Recent Chemical and Pharmacological Developments on 14-Oxygenated-
Spetea M; Schmidhammer H
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577147
[TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of unique morphinan-type molecules: Their application to the search for the unexplored binding domain between opioid receptors and morphinan ligands.
Maeda K; Sugai T; Tokuda A; Kajino K; Saitoh T; Nagase H; Kutsumura N
Bioorg Med Chem Lett; 2024 Feb; 99():129611. PubMed ID: 38228254
[TBL] [Abstract][Full Text] [Related]
25. Discovery of ITI-333, a Novel Orally Bioavailable Molecule Targeting Multiple Receptors for the Treatment of Pain and Other Disorders.
Li P; Zhang Q; Zheng H; Qiao Y; Snyder GL; Martin T; Yao W; Zhang L; Davis RE
J Med Chem; 2024 Jun; 67(11):9355-9373. PubMed ID: 38805667
[TBL] [Abstract][Full Text] [Related]
26. Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy.
Olson KM; Devereaux AL; Chatterjee P; Saldaña-Shumaker SL; Shafer A; Plotkin A; Kandasamy R; MacKerell AD; Traynor JR; Cunningham CW
Front Pharmacol; 2023; 14():1230053. PubMed ID: 37469877
[No Abstract] [Full Text] [Related]
27. Antinociceptive and Cytotoxic Activity of Opioid Peptides with Hydrazone and Hydrazide Moieties at the C-Terminus.
Dyniewicz J; Lipiński PFJ; Kosson P; Bochyńska-Czyż M; Matalińska J; Misicka A
Molecules; 2020 Jul; 25(15):. PubMed ID: 32731576
[TBL] [Abstract][Full Text] [Related]
28. Structure-based design of bitopic ligands for the µ-opioid receptor.
Faouzi A; Wang H; Zaidi SA; DiBerto JF; Che T; Qu Q; Robertson MJ; Madasu MK; El Daibani A; Varga BR; Zhang T; Ruiz C; Liu S; Xu J; Appourchaux K; Slocum ST; Eans SO; Cameron MD; Al-Hasani R; Pan YX; Roth BL; McLaughlin JP; Skiniotis G; Katritch V; Kobilka BK; Majumdar S
Nature; 2023 Jan; 613(7945):767-774. PubMed ID: 36450356
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and investigations of double-pharmacophore ligands for treatment of chronic and neuropathic pain.
Vardanyan R; Vijay G; Nichol GS; Liu L; Kumarasinghe I; Davis P; Vanderah T; Porreca F; Lai J; Hruby VJ
Bioorg Med Chem; 2009 Jul; 17(14):5044-53. PubMed ID: 19540763
[TBL] [Abstract][Full Text] [Related]
30. Ligand-specific recycling profiles determine distinct potential for chronic analgesic tolerance of delta-opioid receptor (DOPr) agonists.
Bagheri Tudashki H; Haddad Y; Charfi I; Couture R; Pineyro G
J Cell Mol Med; 2020 May; 24(10):5718-5730. PubMed ID: 32279433
[TBL] [Abstract][Full Text] [Related]
31. Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor.
Che T; Majumdar S; Zaidi SA; Ondachi P; McCorvy JD; Wang S; Mosier PD; Uprety R; Vardy E; Krumm BE; Han GW; Lee MY; Pardon E; Steyaert J; Huang XP; Strachan RT; Tribo AR; Pasternak GW; Carroll FI; Stevens RC; Cherezov V; Katritch V; Wacker D; Roth BL
Cell; 2018 Jan; 172(1-2):55-67.e15. PubMed ID: 29307491
[TBL] [Abstract][Full Text] [Related]
32. Morphinan Evolution: The Impact of Advances in Biochemistry and Molecular Biology.
Kajino K; Tokuda A; Saitoh T
J Biochem; 2024 Mar; 175(4):337-355. PubMed ID: 38382631
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of new opioid agonist and neurokinin-1 antagonist bivalent ligands.
Vardanyan R; Kumirov VK; Nichol GS; Davis P; Liktor-Busa E; Rankin D; Varga E; Vanderah T; Porreca F; Lai J; Hruby VJ
Bioorg Med Chem; 2011 Oct; 19(20):6135-42. PubMed ID: 21925887
[TBL] [Abstract][Full Text] [Related]
34. Towards Multitargeted Ligands as Pain Therapeutics: Dual Ligands of the Ca
Wegert A; Monnee M; de Graaf W; van Holst F; Bolcato G; Díaz JL; Dordal A; Portillo-Salido E; Reinoso RF; Yeste S; Torrens A; Almansa C
ChemMedChem; 2024 May; 19(10):e202300473. PubMed ID: 38230842
[TBL] [Abstract][Full Text] [Related]
35. Probes for narcotic receptor mediated phenomena. Part 42: synthesis and in vitro pharmacological characterization of the N-methyl and N-phenethyl analogues of the racemic ortho-c and para-c oxide-bridged phenylmorphans.
Kim JH; Deschamps JR; Rothman RB; Dersch CM; Folk JE; Cheng K; Jacobson AE; Rice KC
Bioorg Med Chem; 2011 Jun; 19(11):3434-43. PubMed ID: 21570305
[TBL] [Abstract][Full Text] [Related]
36. Systematic Structure-Activity Relationship Study of Nalfurafine Analogues toward Development of Potentially Nonaddictive Pain Management Treatments.
St Onge CM; Pagare PP; Zheng Y; Arriaga M; Stevens DL; Mendez RE; Poklis JL; Halquist MS; Selley DE; Dewey WL; Banks ML; Zhang Y
J Med Chem; 2024 Jun; 67(11):9552-9574. PubMed ID: 38814086
[TBL] [Abstract][Full Text] [Related]
37. A Novel Bifunctional μOR Agonist and σ
Miao Z; Zhong Y; Gan Y; Fu K; Liu W; Cao Z; Zhao T; Li Z; Hai A; Peng Y; Zuo Z; Zhang T; Hu S; Chen C; Kang T; Huang T; Guo D; Ke B
J Med Chem; 2023 Dec; 66(23):16257-16275. PubMed ID: 38015878
[TBL] [Abstract][Full Text] [Related]
38.
McClain SP; Ma X; Johnson DA; Johnson CA; Layden AE; Yung JC; Lubejko ST; Livrizzi G; Jenny He X; Zhou J; Ventriglia E; Rizzo A; Levinstein M; Gomez JL; Bonaventura J; Michaelides M; Banghart MR
bioRxiv; 2023 Feb; ():. PubMed ID: 36778286
[TBL] [Abstract][Full Text] [Related]
39. C(21)-Di- and monofluorinated scaffold for thevinol/orvinol-based opioid receptor ligands.
Zelentsova MV; Sandulenko IV; Ambartsumyan AA; Danshina AA; Moiseev SK
Org Biomol Chem; 2023 Nov; 21(45):9091-9100. PubMed ID: 37947030
[TBL] [Abstract][Full Text] [Related]
40. The protective effect of hydromorphone to ischemia in rat glial cells.
Kim YS; Kim WY; Kim YH; Yoo JW; Min TJ
Springerplus; 2016; 5():610. PubMed ID: 27247906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
